Clearline Capital’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
Clearline Capital's TTPH Position: Q4 2016 in Review
Clearline Capital sold out of Tetraphase Pharmaceuticals (TTPH) in Q4 2016, closing a stake of 13,396 shares — an estimated $1.03M sold.
Clearline Capital first reported a position in TTPH in Q1 2016 and held it in 3 quarters. The position peaked at $1.93M in Q1 2016. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.
- Clearline Capital reported no remaining Tetraphase Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Clearline Capital sold 13,396 Tetraphase Pharmaceuticals shares in Q4 2016, an estimated $1.03M.
- Clearline Capital first reported a position in Tetraphase Pharmaceuticals in Q1 2016 and held it in 3 quarters.
- Clearline Capital's Tetraphase Pharmaceuticals position peaked at $1.93M in Q1 2016.
- 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q4 2016.
Based on Clearline Capital's 13F filing for Q4 2016, filed 14 Feb 2017.